Cerebral white matter lesions and the risk of dementia

Archives of Neurology

Volumn 61, Issue 10, 2004, Pages 1531-1534

  Prins, Niels D ^a   Van Dijk, Ewoud J ^a   Den Heijer, Tom ^a   Vermeer, Sarah E ^a   Koudstaal, Peter J ^a   Oudkerk, Matthijs ^b   Hofman, Albert ^a   Breteler, Monique M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN CORTEX; BRAIN INJURY; BRAIN VENTRICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HUMAN; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; WHITE MATTER;

AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN DISEASES; CEREBRAL CORTEX; CROSS-SECTIONAL STUDIES; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; STATISTICS;

EID: 5344253243     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.10.1531     Document Type: Article

References (24)

1. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1:426-436.
2. Leys D, Henon H, Pasquier F. White matter changes and poststroke dementia. Dement Geriatr Cogn Disord. 1998;9(suppl 1):25-29.
3. O'Brien JT, Ames D. White matter lesions in depression and Alzheimer's disease. Br J Psychiatry. 1996;169:671.
4. Kuller LH, Lopez OL, Newman A, et al. Risk factors for dementia in the cardiovascular Health Cognition Study. Neuroepidemiology. 2003;22:13-22.
5. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215-1222.
6. de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol. 2000;47:145-151.
7. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." J Psychiatr Res. 1975;12:189-198.
8. Copeland JR, Kelleher MJ, Kellett JM, et al. A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly. Psychol Med. 1976;6:439-449.
9. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX. Br J Psychiatry. 1986;149:698-709.
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
11. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease. Neurology. 1984;34:939-944.
12. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Neurology. 1993;43:250-260.
13. UNESCO. International Standard Classification of Education (ISCED). Paris, France: UNESCO: 1976.
14. Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991;337:1158-1159.
15. Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB. The preclinical phase of alzheimer disease. Arch Neurol. 2000;57:808-813.
16. Barber R, Scheltens P, Gholkar A, et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry. 1999;67:66-72.
17. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis. Stroke. 1997;28:652-659.
18. Filley CM. The behavioral neurology of cerebral white matter. Neurology. 1998;50:1535-1540.
19. Fazekas F, Kapeller P, Schmidt R, Offenbacher H, Payer F, Fazekas G. The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer's disease. J Neuro Sci. 1996;142:121-125.
20. Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT. MRI volumetric correlates of white matter lesions in dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry. 2000;15:911-916.
21. Selden NR, Gitelman DR, Salamon-Murayama N, Parrish TB, Mesulam MM. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain. 1998;121:2249-2257.
22. Bozzali M, Falini A, Franceschi M, et al. White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 2002;72:742-746.
23. Takahashi S, Yonezawa H, Takahashi J, Kudo M, Inoue T, Tohgi H. Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging. Neurosci Lett. 2002;332:45-48.
24. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet. 2001;357:169-175.